2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$59.51-$0.48 (-0.81%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.7BMarket Cap
- 162.88%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$59.51-$0.48 (-0.81%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.99 | ||
Change | +$2.48 (+4.31%) | ||
Open | $58.95 | ||
High | $60.04 | ||
Low | $57.54 | ||
Previous Close | $57.51 | ||
Volume | 407,255 | ||
30-Day Average Volume | 569,685 | ||
1-Week Change | 0.81% | ||
1-Month Change | 0.47% | ||
1-Year Change | 162.88% | ||
3-Year Change | 199.50% | ||
5-Year Change | 143.07% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $329.7M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$52.9M | ||
Free Cash Flow | -$25.9M | ||
EBIT | -$52.8M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $274.4M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 59 | ||
P/B | 137 | ||
P/E | -33 | ||
PEG | 0 | ||
Price/Free Cash Flow | -67 | ||
Price/Operating Cash Flow | -67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue